Dalbraminol

{{Short description|Chemical compound}}

{{cs1 config |name-list-style=vanc |display-authors=6}}

{{Infobox drug

| drug_name =

| IUPAC_name = 1-Phenoxy-3-({2-[(1,3,5-trimethyl-1H-pyrazol-4-yl)amino]ethyl}amino)-2-propanol

| image = Dalbraminol.svg

| alt =

| caption =

| tradename =

| Drugs.com =

| MedlinePlus =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category=

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| ATCvet =

| ATC_prefix = none

| ATC_suffix =

| CAS_number = 81528-80-5

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 7GDN12Q42M

| ChEMBL = 2106134

| PubChem = 205958

| ChemSpiderID = 178459

| DrugBank =

| C=17 | H=26 | N=4 | O=2

| smiles = CC1=C(C(=NN1C)C)NCCNCC(COC2=CC=CC=C2)O

| StdInChI = 1S/C17H26N4O2/c1-13-17(14(2)21(3)20-13)19-10-9-18-11-15(22)12-23-16-7-5-4-6-8-16/h4-8,15,18-19,22H,9-12H2,1-3H3

| StdInChIKey = CRKZWPJRHFAGCJ-UHFFFAOYSA-N

}}

Dalbraminol is a beta blocker.{{US patent reference | number = 4438128 | date = 3-20-1984 | title = Cardioactive aryloxypropanolamines }}{{cite book | vauthors = Morton IK, Hall JM | title = Concise Dictionary of Pharmacological Agents Properties and Synonyms | date = 2012 |isbn=978-94-010-5907-7 | page = 90 }}